BlackRock Fund Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-1,058,768
| Closed | -$103M | – | 3967 |
|
|
2015
Q1 | $103M | Buy |
1,058,768
+119,422
| +13% | +$11.6M | 0.02% | 970 |
|
|
2014
Q4 | $87.2M | Buy |
939,346
+70,643
| +8% | +$6.55M | 0.02% | 1051 |
|
|
2014
Q3 | $59.7M | Buy |
868,703
+2,392
| +0.3% | +$165K | 0.02% | 1241 |
|
|
2014
Q2 | $90.8M | Sell |
866,311
-31,045
| -3% | -$3.25M | 0.03% | 952 |
|
|
2014
Q1 | $74.5M | Buy |
897,356
+65,335
| +8% | +$5.42M | 0.02% | 1089 |
|
|
2013
Q4 | $53.8M | Buy |
832,021
+87,843
| +12% | +$5.69M | 0.02% | 1346 |
|
|
2013
Q3 | $47.2M | Buy |
744,178
+103,080
| +16% | +$6.53M | 0.02% | 1383 |
|
|
2013
Q2 | $26.9M | Buy |
+641,098
| New | +$26.9M | 0.01% | 1633 |
|